2021 Q1 Form 10-Q Financial Statement

#000143774921012120 Filed on May 14, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $93.00K $3.825M
YoY Change -97.57% -40.26%
Cost Of Revenue $1.994M $8.139M
YoY Change -75.5% -9.17%
Gross Profit -$1.901M -$4.314M
YoY Change -55.93% 68.65%
Gross Profit Margin -2044.09% -112.78%
Selling, General & Admin $3.814M $2.627M
YoY Change 45.18% 25.57%
% of Gross Profit
Research & Development $1.378M $580.0K
YoY Change 137.59% -40.7%
% of Gross Profit
Depreciation & Amortization $1.149M $1.643M
YoY Change -30.07% 1.92%
% of Gross Profit
Operating Expenses $7.977M $3.662M
YoY Change 117.83% 19.28%
Operating Profit -$9.878M -$7.976M
YoY Change 23.85% 41.72%
Interest Expense $5.000K -$640.0K
YoY Change -100.78% 25.49%
% of Operating Profit
Other Income/Expense, Net -$179.0K -$1.277M
YoY Change -85.98% 151.38%
Pretax Income -$10.06M -$9.250M
YoY Change 8.76% 50.65%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$10.06M -$9.253M
YoY Change 8.69% 50.8%
Net Earnings / Revenue -10813.98% -241.91%
Basic Earnings Per Share -$0.05
Diluted Earnings Per Share -$0.05 -$639.3K
COMMON SHARES
Basic Shares Outstanding 183.6M shares 14.62M
Diluted Shares Outstanding 183.6M shares 6.903M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $525.3M $9.300M
YoY Change 5548.39% -73.8%
Cash & Equivalents $525.3M $9.289M
Short-Term Investments
Other Short-Term Assets $5.700M $3.800M
YoY Change 50.0% 100.0%
Inventory $2.452M $2.680M
Prepaid Expenses
Receivables $92.00K $152.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $533.5M $15.96M
YoY Change 3243.09% -61.71%
LONG-TERM ASSETS
Property, Plant & Equipment $70.70M $65.86M
YoY Change 7.35% -3.22%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $1.500M
YoY Change
Other Assets $2.800M $800.0K
YoY Change 250.0% -33.33%
Total Long-Term Assets $75.20M $68.20M
YoY Change 10.26% -2.26%
TOTAL ASSETS
Total Short-Term Assets $533.5M $15.96M
Total Long-Term Assets $75.20M $68.20M
Total Assets $608.7M $84.16M
YoY Change 623.28% -24.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.800M $900.0K
YoY Change 322.22% -60.87%
Accrued Expenses $5.900M $3.600M
YoY Change 63.89% 38.46%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.016M $14.40M
YoY Change -92.94% 10.77%
Total Short-Term Liabilities $10.73M $19.00M
YoY Change -43.55% 3.95%
LONG-TERM LIABILITIES
Long-Term Debt $212.0K $200.0K
YoY Change 6.0%
Other Long-Term Liabilities $2.099M $435.0K
YoY Change 382.53% -33.49%
Total Long-Term Liabilities $2.311M $435.0K
YoY Change 431.26% -33.49%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.73M $19.00M
Total Long-Term Liabilities $2.311M $435.0K
Total Liabilities $13.04M $19.67M
YoY Change -33.72% 3.88%
SHAREHOLDERS EQUITY
Retained Earnings -$508.2M -$467.2M
YoY Change 8.77% 7.3%
Common Stock $1.981M $145.0K
YoY Change 1266.21% 21.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $595.7M $64.49M
YoY Change
Total Liabilities & Shareholders Equity $608.7M $84.16M
YoY Change 623.28% -24.49%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income -$10.06M -$9.253M
YoY Change 8.69% 50.8%
Depreciation, Depletion And Amortization $1.149M $1.643M
YoY Change -30.07% 1.92%
Cash From Operating Activities -$7.165M -$6.975M
YoY Change 2.72% 22.2%
INVESTING ACTIVITIES
Capital Expenditures $4.630M $801.0K
YoY Change 478.03% -63.66%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$4.630M -$790.0K
YoY Change 486.08% -64.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $489.4M $958.0K
YoY Change 50982.78% -90.3%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $458.8M 752.0K
YoY Change 60907.98% -92.2%
NET CHANGE
Cash From Operating Activities -$7.165M -6.975M
Cash From Investing Activities -$4.630M -790.0K
Cash From Financing Activities $458.8M 752.0K
Net Change In Cash $447.0M -7.013M
YoY Change -6473.66% -504.91%
FREE CASH FLOW
Cash From Operating Activities -$7.165M -$6.975M
Capital Expenditures $4.630M $801.0K
Free Cash Flow -$11.80M -$7.776M
YoY Change 51.68% -1.72%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
Gevo, Inc.
CY2021Q1 dei Entity Shell Company
EntityShellCompany
false
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001392380
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
198150332
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2021Q1 dei Trading Symbol
TradingSymbol
gevo
CY2021Q1 gevo Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
0
CY2021Q1 gevo Common Shares Issued Upon Exercise Of Warrants
CommonSharesIssuedUponExerciseOfWarrants
30226244
CY2021Q1 gevo Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
4508000
CY2020Q4 gevo Deposits And Other Assets Noncurrent
DepositsAndOtherAssetsNoncurrent
2421000
CY2021Q1 gevo Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
301000
CY2021Q1 gevo Gain Loss From Change In Fair Value Of Warrant Liabilities
GainLossFromChangeInFairValueOfWarrantLiabilities
-53000
CY2020Q1 gevo Gain Loss From Change In Fair Value Of Warrant Liabilities
GainLossFromChangeInFairValueOfWarrantLiabilities
7000
CY2021Q1 gevo Gain Loss From Change In Fair Value Of Warrant Liabilities Net Of Exercises
GainLossFromChangeInFairValueOfWarrantLiabilitiesNetOfExercises
-53000
CY2020Q1 gevo Gain Loss From Change In Fair Value Of Warrant Liabilities Net Of Exercises
GainLossFromChangeInFairValueOfWarrantLiabilitiesNetOfExercises
7000
CY2021Q1 gevo Intercompany Sales
IntercompanySales
0
CY2020 gevo Intercompany Sales
IntercompanySales
100000
CY2021Q1 gevo Issuance Of Common Stock Net Of Issue Costs And Warrants
IssuanceOfCommonStockNetOfIssueCostsAndWarrants
457690000
CY2020Q1 gevo Issuance Of Common Stock Net Of Issue Costs And Warrants
IssuanceOfCommonStockNetOfIssueCostsAndWarrants
906000
CY2021Q1 gevo Lessee Operating Lease Lease Not Yet Commenced Amount
LesseeOperatingLeaseLeaseNotYetCommencedAmount
2
CY2021Q1 gevo Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
1030000
CY2021Q1 gevo Original Issue Discount Paid With Notes Issuance
OriginalIssueDiscountPaidWithNotesIssuance
CY2020Q1 gevo Original Issue Discount Paid With Notes Issuance
OriginalIssueDiscountPaidWithNotesIssuance
282000
CY2021Q1 gevo Other Revenues
OtherRevenues
80000
CY2020Q1 gevo Other Revenues
OtherRevenues
CY2021Q1 gevo Other Revenues Including Grants
OtherRevenuesIncludingGrants
80000
CY2020Q1 gevo Other Revenues Including Grants
OtherRevenuesIncludingGrants
CY2021Q1 gevo Preliminary Stage Project Costs
PreliminaryStageProjectCosts
2727000
CY2020Q1 gevo Preliminary Stage Project Costs
PreliminaryStageProjectCosts
156000
CY2021Q1 gevo Stock Issued During Period Value Upon Exercise Of Warrants
StockIssuedDuringPeriodValueUponExerciseOfWarrants
1117000
CY2021Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
9710000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4125000
CY2021Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
3841000
CY2020Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
897000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
92000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
527000
CY2021Q1 us-gaap Accrued Utilities Current
AccruedUtilitiesCurrent
58000
CY2020Q4 us-gaap Accrued Utilities Current
AccruedUtilitiesCurrent
5000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
60260000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
59117000
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1101939000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
643269000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
562000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
336000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
925000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
172000
CY2021Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2000
CY2020Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
150000
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
220099
CY2020Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6837786
CY2021Q1 us-gaap Assets
Assets
608728000
CY2020Q4 us-gaap Assets
Assets
152099000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
533524000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
83270000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
1282000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
525323000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
78338000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
78338000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16302000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
525323000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
9289000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
446985000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7013000
CY2019Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
30377087
CY2021Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
150843
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
198050449
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
128138311
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
198050449
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
128138311
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
1981000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
8139000
CY2021Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;"><div style="display: inline; background-color:null;"><div style="display: inline; font-style: italic;">Concentration of Business Risk.</div>&nbsp;</div>As of <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021, </div><div style="display: inline; font-style: italic; font: inherit;">four</div>&nbsp;companies, Total Petrochemicals &amp; Refining USA, Inc. ("Total"), Juhl Clean Energy Assets, Inc.&nbsp;("Juhl"), AvFuel Corporation ("AvFuel")&nbsp;and Wisconsin Bioproducts&nbsp;("Wisconsin"), comprised approximately <div style="display: inline; font-style: italic; font: inherit;">41%,</div> <div style="display: inline; font-style: italic; font: inherit;">27%,</div> <div style="display: inline; font-style: italic; font: inherit;">16%</div>&nbsp;and <div style="display: inline; font-style: italic; font: inherit;">14%,</div> or approximately <div style="display: inline; font-style: italic; font: inherit;">98%</div> in total, of the Company's outstanding trade accounts receivable, respectively.&nbsp;As of <div style="display: inline; font-style: italic; font: inherit;"> December&nbsp;</div><div style="display: inline; font-style: italic; font: inherit;">31,</div> <div style="display: inline; font-style: italic; font: inherit;">2020,</div> <div style="display: inline; font-style: italic; font: inherit;">one</div>&nbsp;customer, HCS Group GmbH ("HCS") comprised approximately <div style="display: inline; font-style: italic; font: inherit;">79%</div>&nbsp;of the Company's outstanding trade accounts receivable, respectively.</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;">&nbsp;</div> <div style=" font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;">For the <div style="display: inline; font-style: italic; font: inherit;">three</div> months ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2021, </div>New Vision, LLC ("New Vision") and Av Fuel&nbsp;accounted for approximately <div style="display: inline; font-style: italic; font: inherit;">79%</div>&nbsp;and <div style="display: inline; font-style: italic; font: inherit;">15%,</div> or approximately <div style="display: inline; font-style: italic; font: inherit;">94%</div> in total,&nbsp;of the Company's consolidated revenue, respectively. For the <div style="display: inline; font-style: italic; font: inherit;">three</div> months ended <div style="display: inline; font-style: italic; font: inherit;"> March 31, 2020, </div>Eco-Energy, LLC ("Eco-Energy")&nbsp;and Purina Animal Nutrition, LLC ("Purina") represented approximately <div style="display: inline; font-style: italic; font: inherit;">73%</div> and <div style="display: inline; font-style: italic; font: inherit;">22%,</div> or approximately <div style="display: inline; font-style: italic; font: inherit;">95%</div> in total,&nbsp;of the Company's consolidated revenue, respectively. Total, AvFuel, Wisconsin and&nbsp;HCS&nbsp;are&nbsp;customers of the Company's Gevo segment. New Vision, Eco-Energy&nbsp;and&nbsp;Purina&nbsp;are customers of the Company's Agri-Energy segment (see Note <div style="display: inline; font-style: italic; font: inherit;">14</div>).</div></div></div></div></div></div></div></div></div></div></div></div></div></div>
CY2021Q1 us-gaap Contract With Customer Asset Credit Loss Expense
ContractWithCustomerAssetCreditLossExpense
0
CY2020 us-gaap Contract With Customer Asset Credit Loss Expense
ContractWithCustomerAssetCreditLossExpense
0
CY2021Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2020Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
0
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1994000
CY2021Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1149000
CY2020Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
1649000
CY2021Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1144000
CY2020Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1643000
CY2021Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2020Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.64
CY2021Q1 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
CY2020Q1 us-gaap Embedded Derivative Gain Loss On Embedded Derivative Net
EmbeddedDerivativeGainLossOnEmbeddedDerivativeNet
-100000
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1677000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1960000
CY2021Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
11000
CY2020Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
1000
CY2021Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
6000
CY2020Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
1000
CY2020Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.21
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
167000
CY2021Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
5000
CY2021Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
163000
CY2021Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
426000
CY2021Q1 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
26000
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
22000
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
26000
CY2021Q1 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
26000
CY2021Q1 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
25000
CY2021Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
263000
CY2021Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
7000
CY2020Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
CY2021Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.13
CY2021Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P18Y150D
CY2020Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P4Y330D
CY2021Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
CY2020Q1 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-669000
CY2021Q1 us-gaap Gross Profit
GrossProfit
-1901000
CY2020Q1 us-gaap Gross Profit
GrossProfit
-4314000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
4545000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1137000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-435000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-983000
CY2021Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-39000
CY2020Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-520000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4273000
CY2020Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
545000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
3000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
395000
CY2021Q1 us-gaap Inventory Net
InventoryNet
2452000
CY2020Q4 us-gaap Inventory Net
InventoryNet
2491000
CY2021Q1 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
1365000
CY2020Q4 us-gaap Inventory Parts And Components Net Of Reserves
InventoryPartsAndComponentsNetOfReserves
1361000
CY2021Q1 us-gaap Lease Cost
LeaseCost
243000
CY2020Q1 us-gaap Lease Cost
LeaseCost
584000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6975000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-10057000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2801000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
24000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1042000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-9253000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
305000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
297000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
103000
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1138000
CY2021Q1 us-gaap Liabilities
Liabilities
13037000
CY2020Q4 us-gaap Liabilities
Liabilities
5720000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
608728000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
152099000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
10726000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4932000
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1016000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
807000
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
212000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
447000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
458780000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
752000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4630000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-790000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7165000
CY2021Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
999000
CY2020Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
380000
CY2021Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-179000
CY2020Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1277000
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
7977000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
3662000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-9878000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-7976000
CY2021Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
61000
CY2020Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
471000
CY2021Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
100000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
1663000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
61000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
471000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
17000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
15000
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.05
CY2020Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.12
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y300D
CY2020Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y180D
CY2021Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
4134000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1263000
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2099000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
341000
CY2021Q1 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
212000
CY2020Q4 us-gaap Other Long Term Notes Payable
OtherLongTermNotesPayable
447000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-121000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
30000
CY2021Q1 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
1016000
CY2020Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
807000
CY2021Q1 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
31683000
CY2020Q1 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
52000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5432000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
801000
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5657000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1914000
CY2021Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt">Reclassifications.</div>&nbsp;The Company&nbsp;reclassified certain prior period amounts to conform to the current period presentation, including the categorization of preliminary stage project costs on the Consolidated Statements of Operations. These reclassifications&nbsp;had <div style="display: inline; font-style: italic; font: inherit;">no</div> impact on total revenues, total cost of goods sold, total operating expenses, net loss or stockholders' equity for any period.</div></div></div></div></div></div></div></div></div></div></div></div>
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
489373000
CY2020Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
958000
CY2021Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
321900000
CY2021Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1117000
CY2020Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
130956000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
125525000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
70696000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
66408000
CY2021Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
27000
CY2020Q1 us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
154000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1378000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
580000
CY2021Q1 us-gaap Restructuring Charges
RestructuringCharges
CY2020Q1 us-gaap Restructuring Charges
RestructuringCharges
299000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-508229000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-498172000
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
13000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3825000
CY2021Q1 us-gaap Revenues
Revenues
93000
CY2020Q1 us-gaap Revenues
Revenues
3825000
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
13000
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1562000
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2021Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3872000
CY2020Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2627000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
925000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
172000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1517
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
548.75
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
35
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1552
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1517
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
556.13
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
548.75
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1517
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
548.75
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
876
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2021Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
20
CY2021Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
99300
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y131D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y211D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y131D
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y131D
CY2021Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
132000
CY2020Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
80000
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2021Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
595691000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
146379000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
72504000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
64493000
CY2021Q1 us-gaap Variable Lease Cost
VariableLeaseCost
39000
CY2020Q1 us-gaap Variable Lease Cost
VariableLeaseCost
32000
CY2021Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
183566524
CY2020Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
14472798

Files In Submission

Name View Source Status
0001437749-21-012120-index-headers.html Edgar Link pending
0001437749-21-012120-index.html Edgar Link pending
0001437749-21-012120.txt Edgar Link pending
0001437749-21-012120-xbrl.zip Edgar Link pending
ex_235838.htm Edgar Link pending
ex_235839.htm Edgar Link pending
ex_235840.htm Edgar Link pending
ex_248694.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gevo-20210331.xml Edgar Link completed
gevo-20210331.xsd Edgar Link pending
gevo-20210331_cal.xml Edgar Link unprocessable
gevo-20210331_def.xml Edgar Link unprocessable
gevo-20210331_lab.xml Edgar Link unprocessable
gevo-20210331_pre.xml Edgar Link unprocessable
gevo20210331_10q.htm Edgar Link pending
logo.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending